Oxford Asset Management’s Minerva Neurosciences NERV Stock Holding History

Oxford Asset Management’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,235	Closed	-$635K	–	1976
2019 Q3	$635K	Sell	10,235 -6,656	-39%	-$377K	0.02%	1158
2019 Q2	$761K	Buy	16,891 +469	+3%	+$23.5K	0.02%	1101
2019 Q1	$1.03M	Sell	16,422 -381	-2%	-$22.9K	0.02%	920
2018 Q4	$906K	Buy	16,803 +7,500	+81%	+$549K	0.02%	918
2018 Q3	$933K	Buy	+9,303	New	+$699K	0.02%	1036
2018 Q2	–	Sell	-1,955	Closed	-$98K	–	1847
2018 Q1	$98K	Buy	+1,955	New	+$93.9K	﹤0.01%	1537
2017 Q1	–	Sell	-2,322	Closed	-$218K	–	1443
2016 Q4	$218K	Buy	+2,322	New	+$237K	0.01%	693

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

IVAI

Index Venture Associates IV St. Helier, Channel Islands, Jersey $6.24M AUM

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Oxford Asset Management's NERV Position: Q4 2019 in Review

Oxford Asset Management sold out of Minerva Neurosciences (NERV) in Q4 2019, closing a stake of 10,235 shares — an estimated $635K sold.

Oxford Asset Management first reported a position in NERV in Q4 2016 and held it in 7 quarters. The position peaked at $1.03M in Q1 2019. 92 funds tracked by Wall St. Rank hold NERV as of Q4 2019.

Oxford Asset Management reported no remaining Minerva Neurosciences position as of Q4 2019 after selling out during the quarter.
Oxford Asset Management sold 10,235 Minerva Neurosciences shares in Q4 2019, an estimated $635K.
Oxford Asset Management first reported a position in Minerva Neurosciences in Q4 2016 and held it in 7 quarters.
Oxford Asset Management's Minerva Neurosciences position peaked at $1.03M in Q1 2019.
92 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2019.

Based on Oxford Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.